Medicines: Identifying, Exposing and Tackling Unethical and Corrupt Practices is Essential for Safeguarding Patient and Public Health Interests Worldwide
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 16631
Special Issue Editor
Interests: chelation therapy; chelation in medicine; chelating drugs; iron chelating drugs in thalassaemia and other diseases of iron overload or imbalance; chelator antioxidants in free radical pathology; chelators and antioxidants in cancer and neurodegenerative diseases; chelating drug design, development and clinical use
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Issues surrounding health care affect all people worldwide. High rates of morbidity and mortality are observed due to the lack of medicines, medical devises and because of low standards of health care services in many countries as a result of insufficient resources. COVID-19 and other communicable diseases highlight the interdependence of nations on health and the need for one world / one health policies, as well as access to water, food and medicines as a human right. High standard global health care can be achieved by the redistribution of wealth and resources, as well as tackling corruption, fraud and unethical practices, which are a cause of massive drainage on health resources worldwide.
The aim of the special issue is to use analytical tools and methods in order to address corrupt and unethical practices, highlight their implications in everyday life and at all levels in health care and academia, with the priority being the need for accessible health care, medicines and medical devices for all people. Most importantly colleagues from public health institutions, academic and research communities are invited to share their experience, identify and highlight associated problems and suggest the appropriate analytical tools, list the criteria and find solutions to unethical and corrupt practices in all sectors of public health including medicines and medical devices.
Prof. Dr. George J. Kontoghiorghes
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Medicines
- Global health care
- Patient care-all specialties
- Corruption in public health
- Corruption in academia
- Corruption in national health institutions
- Corruption in international health institutions
- Tackling corruption
- Analytical tools and methods
- Pharmaceutical industry
- Plagiarism
- Nepotism
- Victimization
- Patient rights
- Orphan diseases
- Orphan drugs
- Patent issues
- Drug marketing
- Elite journals
- Risk/benefit assessment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.